Skip to content
Medical Health Aged Care

Dr. Daniel Pascheles Rejoins Molekule Consulting as Strategic Advisor

Molekule Consulting, LLC 2 mins read

MIAMI, FL / ACCESSWIRE / October 30, 2023 / In a significant development that promises to shape the future of Molekule Consulting, we are thrilled to announce the return of Dr. Daniel Pascheles as a Strategic Advisor.

Molekule Consulting
Molekule Consulting
www.molekuleconsulting.com

Dr. Pascheles, with an illustrious career spanning over 30 years in the biopharmaceutical competitive and strategic intelligence sector, is poised to bring a wealth of knowledge and expertise to Molekule. His previous roles include leading Competitive Intelligence & Strategy functions at industry leaders Merck & Co./MSD and Aventis, in addition to serving as CEO of Molekule Consulting.

"Dr. Pascheles' return-to-Molekule marks a thrilling, new chapter in our shared story. His homecoming is not just a reunion, but a renewal of our mutual commitment to excellence and innovation. Welcome back, Dr. Pascheles!" expressed David Alderman, President & CEO at Molekule Consulting.

In his pivotal role as Strategic Advisor, Dr. Pascheles will employ his vast industry expertise and strategic prowess to shape and foster Molekule's trajectory of growth and value journey into the future.

"I am thrilled to be back!" remarked Dr. Pascheles. "It is with great excitement that I rejoin the dynamic and growing team at Molekule, and I eagerly anticipate contributing to the company's ongoing success."

For further details on this exciting development, please contact David Alderman at [email protected]; +1 305.504.3030.

About Molekule Consulting:

Molekule Consulting provides best-in-class strategic intelligence and is solely dedicated to the biopharma sector. We shape the path forward with our strategic intelligence, driving transformative changes across the biopharmaceutical landscape.

Our purpose is clear: to provide high-impact, actionable insights that catalyze growth and foster innovation for biopharmaceutical brands, franchises, and businesses. Our clientele encompasses industry titans, robust mid-sized companies, and ambitious newcomers within the global biopharmaceutical realm.

Interested in learning more about Molekule Consulting's biopharmaceutical-focused strategies and market intelligence? Dive deeper here: www.molekuleconsulting.com

Contact Information

David Alderman
President & CEO
[email protected]
+1 305.504.3030

SOURCE: Molekule Consulting

.


View source version on accesswire.com:
https://www.accesswire.com/797610/dr-daniel-pascheles-rejoins-molekule-consulting-as-strategic-advisor

More from this category

  • Medical Health Aged Care
  • 11/03/2026
  • 00:10
Egg Medical, Inc.

Egg Medical Presents CRT 2026 Data Demonstrating a Responsible Path to Light Lead and Lead-Apron Free Protection

WASHINGTON, March 10, 2026 (GLOBE NEWSWIRE) -- Egg Medical, a leader in enhanced radiation protection devices (ERPD), today announced the results of a Late-Breaking Trial presented at the Cardiovascular Research Technologies (CRT) 2026 conference. The study, presented by Santiago Garcia, MD, of The Christ Hospital, confirms that the addition of the EggNest™ system reduces levels of scatter radiation to all members of the interventional team to the extent that users could do procedures safely without the use of lead aprons or wear ultralight aprons.“For decades, the interventional community has accepted a trade-off: protect your long-term health from the effects of…

  • Medical Health Aged Care
  • 10/03/2026
  • 20:11
Ferring Pharmaceuticals

For the First Time, Ferring Reports Revenue of Over €2.5 Billion in 2025

Ferring’s total revenues for 2025 exceeded €2.5 billion, an increase of 10% from 2024, mainly driven by our flagship product Menopur® Continued ramp-up in…

  • Contains:
  • Legal, Medical Health Aged Care
  • 10/03/2026
  • 17:30
Maddens Lawyers

Thousands register to participate in the Dr Lanzer Class Action

Patients who underwent cosmetic surgery at the Lanzer Clinics have until 4.00pm Friday 10 April to register or opt out of a class action set for trial in the Supreme Court of Victoria in September. The class action alleges that Dr Daniel Lanzer and his colleagues Dr Daniel Aronov, Dr Ryan Wells, Dr Alieza Fallahi, Dr George Wong, and Dr Daniel Darbyshire engaged in misleading and negligent practices while performing cosmetic surgeries, with many former patients left with injuries and ongoing pain. Psychologist Candice Wainstein, who is the wife of Dr Aronov, is also a defendant. Maddens Lawyers principal Kathryn…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.